AACR
Accelerate your oncology drug development with Frontage’s integrated, end-to-end CMC solutions. From preclinical formulation to NDA/ANDA submission and commercial supply, our oncology-focused team is here to help you move faster—with confidence.
🔬 Our Oncology CMC Capabilities Include:
- Formulation Development
Tablets, Capsules, Injectables, Topicals, Suspensions, Lyophilized Products, Powder-in-Capsule - Aseptic & Sterile Fill-Finish
Including Pre-filled Syringes (PFS) and High-Potency Compounds – Injectables - Non-Sterile Compounding
Tablets, Capsules, Topicals - Sterile Topicals & Ophthalmics
- HPAPI & Cytotoxic Handling
OEL down to 1 μg/m³ | DEA Schedules I–V - GMP ManufacturingEarly-phase and Pivotal Supplies, Registration Batch, Commercial Manufacturing
- Analytical TestingGMP & GLP-compliant, Method Development to Validation, Release & Stability Testing, Peptide Characterization, Biologics Testing, In-vitro Release, Extractables & Leachables (E&L)
🎯 Oncology-Focused
With deep expertise in oncology—including orphan indications and complex modalities—Frontage provides the infrastructure and know-how to help you navigate regulatory pathways and bring your therapies to market.
🤝 Meet Us at AACR 2025
Are you attending 2025 American Association for Cancer Research annual meeting in Chicago? We’d love to see you there! Stop by our booth #3939 to meet our team!
Interested in setting up a meeting with us at AACR, just reply to this email or click the link below. We hope to see you in Chicago!